Polyendocrine Metabolic Ovarian Syndrome (PMOS), formerly known as Polycystic Ovary Syndrome (PCOS), affects up to 13% of reproductive-aged women globally, yet remains underdiagnosed and inadequately managed across diverse healthcare settings.
This comprehensive certification programme addresses critical knowledge gaps in PMOS care through the latest 2023 International Evidence-based Guideline for the Assessment and Management of PMOS, empowering health professionals to deliver optimal patient outcomes.




